Sun Pharma receives OAI status from USFDA for Dadra facility Ruchika Sharma12 April 2024 11:42 AM ISTMumbai: Sun Pharma has informed in a BSE filing that the US Food and Drug Administration (USFDA) has determined the inspection classification...
Sun Pharmaceutical Industries appoints Dheeraj Sinha as Executive Vice President, Chief Information Officer Ruchika Sharma4 April 2024 11:30 AM ISTMumbai: Sun Pharmaceutical Industries Limited has appointed Dheeraj Sinha as Executive Vice President and Chief Information Officer effective from...
Sailesh T Desai retires from Sun Pharma Board of Directors Ruchika Sharma30 March 2024 11:52 AM ISTMaharashtra: Through a recent BSE filing, Sun Pharma has informed that Sailesh Trambaklal Desai will retire from the Company's Board of...
Sun Pharma gets Australian regulatory nod for acne vulgaris treatment Winlevi Susmita Roy19 March 2024 11:52 AM ISTWinlevi is approved for the topical treatment of acne vulgaris in people 12 years of age and older.
Sun Pharma recalls 55000 bottles of generic drug to treat gout from American market Ruchika Sharma12 March 2024 1:13 PM ISTThe affected lot was produced at Sun Pharma's Dadra-based plant for Memphis-based Northstar Rx LLC, the US regulator noted.
Sun Pharma unit recalls over 54000 bottles of Mesalamine ER capsules in US Ruchika Sharma9 March 2024 11:24 AM ISTThe affected lot of capsules have been manufactured by Sun Pharmaceutical Industries at its Mohali-based manufacturing plant and distributed in the US...
Sun Pharma to buy 16.33 percent stake in Surgimatix for over Rs 25 crore Ruchika Sharma21 Feb 2024 3:21 PM ISTNew Delhi: Pharma major, Sun Pharmaceutical Industries Ltd, on Tuesday said it will acquire a 16.33 per cent stake in Surgimatix, Inc, a US-based firm...
Sun Pharma Gets CDSCO Panel Nod to Study Tildrakizumab Injection 100 mg/ ml Dr. Divya Colin16 Feb 2024 6:00 PM ISTNew Delhi: The drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Sun Pharma reports 16.5 percent rise in net profit to Rs 2,523.8 crore in Q3 Ruchika Sharma1 Feb 2024 3:15 PM ISTMumbai: Sun Pharmaceutical Industries Ltd has reported a 16.52 per cent rise in its consolidated net profit to Rs 2,523.8 crore in the third...
Health Bulletin 31/January/2024 Anshika Mishra31 Jan 2024 4:55 PM ISTHere are the top health news for the day:HC orders Bengal Govt to establish medical board for rape survivors' pregnancy terminationIn a significant...
Sun Pharma gets non-exclusive rights to market second brand of Finerenone in India Ruchika Sharma19 Jan 2024 11:17 AM ISTBayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa.
Sun Pharma to acquire remaining stake in Taro Pharma Ruchika Sharma18 Jan 2024 2:03 PM ISTMumbai: Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. have announced that they have entered into a...
